IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) has received an average rating of “Moderate Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $60.3333.
Several equities analysts have issued reports on the stock. B. Riley Financial decreased their price objective on shares of IperionX from $58.00 to $52.00 and set a “buy” rating for the company in a research note on Friday, March 13th. BTIG Research upped their price objective on shares of IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, June 5th. Alliance Global Partners restated a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. Roth Mkm restated a “buy” rating on shares of IperionX in a research note on Monday, June 8th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research note on Tuesday, April 21st.
Check Out Our Latest Analysis on IperionX
IperionX Stock Performance
Insider Buying and Selling at IperionX
In related news, Chairman Todd Hannigan acquired 260,000 shares of the firm’s stock in a transaction on Wednesday, April 29th. The stock was bought at an average price of $4.20 per share, for a total transaction of $1,092,000.00. Following the completion of the purchase, the chairman directly owned 26,108,334 shares of the company’s stock, valued at approximately $109,655,002.80. The trade was a 1.01% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Anastasios Arima acquired 110,000 shares of the firm’s stock in a transaction on Tuesday, April 28th. The stock was bought at an average price of $4.49 per share, with a total value of $493,900.00. Following the purchase, the chief executive officer directly owned 12,316,782 shares of the company’s stock, valued at $55,302,351.18. This represents a 0.90% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 590,000 shares of company stock valued at $2,571,500 in the last 90 days.
Institutional Investors Weigh In On IperionX
Hedge funds have recently made changes to their positions in the business. Jones Financial Companies Lllp acquired a new stake in shares of IperionX during the third quarter worth about $36,000. JPMorgan Chase & Co. acquired a new stake in shares of IperionX during the second quarter worth about $66,000. State of Tennessee Department of Treasury acquired a new stake in shares of IperionX during the fourth quarter worth about $119,000. DV Equities LLC acquired a new stake in shares of IperionX during the fourth quarter worth about $178,000. Finally, Man Group plc purchased a new position in IperionX during the fourth quarter worth about $257,000. Institutional investors and hedge funds own 2.76% of the company’s stock.
About IperionX
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Featured Stories
- Five stocks we like better than IperionX
- Could a Tesla-SpaceX Merger Be Closer Than Investors Think?
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
